Skip to main content
. 2017 Mar 22;12(3):e0174308. doi: 10.1371/journal.pone.0174308

Fig 3. Comparison of the power of cfDNA and CEA course to reflect the course of disease.

Fig 3

Values are depicted for both therapy naïve patients (A) and patients during further therapy lines (B). A change in cfDNA amount of ≥10% is considered as “increase” /”decrease”. A change in value <10% is defined as “no change”.